Law 677 | Patent Law | Spring 2003

Slides:



Advertisements
Similar presentations
35 U.S.C. § 112, First Paragraph By: Sheetal S. Patel.
Advertisements

Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
Written Description: Whats Up With That? Patent Law Sept. 9, 2004 Prof Merges.
Patent Law and Policy University of Oregon Law School Fall 2009 Elizabeth Tedesco Milesnick Patent Law and Policy, Fall 2009 Class 5, Slide 1.
Incorporation by Reference
Enablement and Written Description Intro to IP – Prof Merges Jan. 19, 2012.
Proteomics Examination Yvonne (Bonnie) Eyler Technology Center 1600 Art Unit 1646 (703)
Utility and Written Description Steve Kunin Deputy Commissioner for Patent Examination Policy Esther Kepplinger Deputy Commissioner for Patent Operations.
1 35 U.S.C. § 112, first paragraph and the Wands Analysis Remy Yucel, SPE 1636 (571)
1 Rule 132 Declarations and Unexpected Results Richard E. Schafer Administrative Patent Judge Board of Patent Appeals and Interferences.
1 35 USC 112, 1 st paragraph enablement Enablement Practice in TC 1600 Deborah Reynolds, SPE
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
Memorandum - 35 U.S.C. 112, Second and Sixth Paragraphs Robert Clarke Director, Office of Patent Legal Administration United States Patent and Trademark.
“REACH-THROUGH CLAIMS”
Recent Developments In Patent Law: Update On Federal Circuit Cases FITZPATRICK, CELLA, HARPER & SCINTO 30 Rockefeller Plaza New.
Patent Processing – Examination Issues Patent, Trademark, and Copyright - Law and Policy 5-8 November 2007 Amman, Jordan Global Intellectual Property Academy.
Intellectual Property Boston College Law School February 25, 2008 Patent - Utility.
Intellectual Property Boston College Law School February 28, 2007 Patent - Enablement.
Intellectual Property Boston College Law School February 27, 2008 Patent - Enablement.
Intellectual Property
Enablement and Written Description Prof. Robert Merges
Intellectual Property Boston College Law School March 3, 2008 Patent - Nonobviousness.
Patent Overview by Jeff Woller. Why have Patents? Patents make some people rich – but, does that seem like something the government should protect? Do.
Intellectual Property Boston College Law School February 16, 2009 Patent – Novelty.
Examination Issues: Immunology Yvonne (Bonnie) Eyler Quality Assurance Specialist Technology Center 1600 USPTO (571)
SECTION 101 OF THE PATENT LAW Describes what is patentable subject matter: "Whoever invents or discovers any new and useful process, machine, manufacture,
1 1 AIPLA Firm Logo American Intellectual Property Law Association Hamilton Beach Brands v. Sunbeam Products: Lessons Learned Naomi Abe Voegtli IP Practice.
Stem Cells Peter Paras, Jr.. 2 Overview Introduction — Definitions Types of Stem Cells — Origin Examination of Stem Cell Claims — Statutes — Sample Claims.
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
International IP Issues Federal Lab Consortium Meeting International IP Issues Dr Roisin McNally - European Patent Attorney 20 September 2006.
©2011 Haynes and Boone, LLP 1 Functional Language in Claims David O’Dell Haynes and Boone LLP
The Patent Document II Class Notes: January 23, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Patent Law Presented by: Walker & Mann, LLP Walker & Mann, LLP 9421 Haven Ave., Suite 200 Rancho Cucamonga, Ca Office.
Patents III Novelty and Loss of Rights Class 13 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
Overcoming Prior Art References Non-Enabling Prior Art References Gary Kunz SPE Art Unit 1616.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
Josiah Hernandez Patentability Requirements. Useful Having utilitarian or commercial value Novel No one else has done it before If someone has done it.
1 Written Description Analysis and Capon v. Eshhar Jeffrey Siew Supervisory Patent Examiner AU 1645 USPTO (571)
Defenses & Counterclaims II Class Notes: March 25, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
New Sections 102 & 103 (b) Conditions for Patentability- (1) IN GENERAL- Section 102 of title 35, United States Code, is amended to read as follows: -`Sec.
Patent Economics I Class Notes: January 16, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
1 Demystifying the Examination of Stem Cell-Related Inventions Remy Yucel, Ph.D. Supervisory Patent Examiner Technology Center 1600 United States Patent.
Examining Claims for Compliance with 35 U.S.C. 112(a): Part II – Enablement Focus on Electrical/Mechanical and Computer/Software-related Claims August.
Vector Claims in Gene Therapy Applications: In vivo vs. In vitro Utilities Deborah Reynolds SPE GAU
The Subject Matter of Patents II Class Notes: April 8, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Patents IV Nonobviousness
Patents I Introduction to Patent Law Class Notes: February 19, 2003 Law 507 | Intellectual Property | Spring 2003 Professor Wagner.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
The Novelty Requirement II Class Notes: February 4, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
The Subject Matter of Patents I Class Notes: April 3, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Obviousness I Class Notes: February 6, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Patents II Disclosure Requirements Class 12 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
Nuts and Bolts of Patent Law presented by: Shamita Etienne-Cummings April 5, 2016.
PATC Module 2 – Infringement/Validity
Written Description Prof. Merges
AIPLA ID Committee Meeting AIPLA Spring Meeting (Seattle) May 2, 2013
Loss of Right Provisions
Law 677 | Patent Law | Spring 2003
Enablement and Written Description
The Novelty Requirement I
Nuts and Bolts of Patent Law
OTHER INVALIDITY CHALLENGES
Patents IV Nonobviousness
Global Innovation Management Workout on Writing a Patent
Enzo Biochem, Inc. v. Gen-Probe Inc. 323 F. 3d 956 C. A. Fed. (N. Y
Patents II Disclosure Requirements
Stem Cells Peter Paras, Jr.
Examination Issues: Immunology
Presentation transcript:

Law 677 | Patent Law | Spring 2003 The Patent Document I Class Notes: January 21, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner

Today’s Agenda The Enablement Requirement The Written Description Requirement Debating the Enablement & W/D Requirements 1/21/03 Law 677 | Spring 2003

The Standards for Patentability A valid patent must be . . . Fully and appropriately described (§ 112) In compliance with statutory bars (§ 102) Novel (§ 102) Nonobvious (§ 103) The work of the inventors (§ 116) Useful (§ 101) Within the appropriate subject matter (§ 101) 1/21/03 Law 677 | Spring 2003

The Enablement Requirement 35 U.S.C. § 112. - Specification The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. . . . 1/21/03 Law 677 | Spring 2003

The Enablement Requirement 35 U.S.C. § 112. - Specification The specification shall contain a [1] written description of the invention, and [2] of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the [3] best mode contemplated by the inventor of carrying out his invention. . . . 1/21/03 Law 677 | Spring 2003

The Enablement Requirement O’Reilly v Morse (1854) Claim 8 (p. 164): “I do not propose to limit myself . . . “The essence of my invention being . . .” Consider: If the enablement requirement has to do with the specification, why the focus on Claim 8? (Is the patent valueless with the loss of Claim 8?) What defect in Claim 8 does the majority object to? (On what philosophical basis, if any, does the objection rest?) How does the dissent respond? (Their theory?) How would you re-write Claim 8 to satisfy the majority? 1/21/03 Law 677 | Spring 2003

The Enablement Requirement The Scope of the Enablement Requirement How might there be said to be two purposes of the enablement requirement? Can you reconcile Morse and the American Bell cases? (p. 172) By what standard should we evaluate the scope of the disclosure? (How does this connect to the twin purposes?) 1/21/03 Law 677 | Spring 2003

The Enablement Requirement In re Glass (CCPA 1974) This rejection is of all claims. What is different here from Morse? What was the problem with the specification? Didn’t the (slightly) subsequent patents support the spec.? What is the date by which disclosure is measured? Is this the right date? (Consider the purposes of Enablement.) Pros and cons? Why would the applicant file an app like this? What would have been the easiest way to avoid this problem? Note a trap: what could the applicant do in response to the PTO rejection? 1/21/03 Law 677 | Spring 2003

The Enablement Requirement The Three Principles of Enablement The scope of disclosure required = scope of the claims. Can you claim more broadly than you disclose? Explain. If some ‘experimentation’ is required to actually make the invention, is the claim enabled? The quantity of disclosure is related to the predictability in the art. Can you rely on ‘state of the art’ for enablement? When should you deposit? Are there risks? The measurement of the disclosure is as of the filing date. What if you haven’t yet “made” your device (reduced it to practice) as of the filing date? 1/21/03 Law 677 | Spring 2003

The Written Description Requirement 35 U.S.C. § 112. - Specification The specification shall contain a [1] written description of the invention, and [2] of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the [3] best mode contemplated by the inventor of carrying out his invention. . . . How does the Written Description requirement differ from enablement? (Statutory clues?) 1/21/03 Law 677 | Spring 2003

The Written Description Requirement Vas-Cath v Mahurkar (Fed. Cir. 1991) (Rich, J.) M wants ‘priority’ from a design patent app. Why? Because of this, what is the court’s real question? How does the court resolve the “range of variation” question? Consider the evidence (p. 221) What does the court say is the true purpose of w/d requirement? What is the “standard”? Is this any different than enablement? 1/21/03 Law 677 | Spring 2003

The Written Description Requirement Gentry Gallery v Berkline (Fed. Cir. 1998) (Lourie, J.) Claims: recliner sofa, controls anywhere Disclosure: recliner sofa, controls on the console Can Gentry Gallery be reconciled with Vas Cath? 1/21/03 Law 677 | Spring 2003

Debating Enablement vs Written Description The Enzo Biochem Cases Enzo I (Fed. Cir., April 2002) (Lourie, J.) Claims to deposited nucleotides insufficient (as a matter of law) to satisfy written description. Is this consistent with Vas Cath? How is this significant doctrinally? Consider: Why does Enzo deposit rather than describe? Why does Enzo claim variations of the material as well? Enzo II (Fed. Cir., July 2002) (Lourie, J.) Claims to deposited nucleotides sufficient to satisfy written description. Enzo III (Fed. Cir., July 2002) (various) (order denying en banc) What do the dissenters say? Do you agree? Will the Court change? (Count the votes.) 1/21/03 Law 677 | Spring 2003

Case Studies: Complex Technology Next Class The Patent Document II Best Mode Case Studies: Complex Technology Inventorship 1/21/03 Law 677 | Spring 2003